[ Skyline Vet Pharma raises $5M in Series A ]
Skyline Vet Pharma has raised $5 million in Series A funding.
Founded in 2015, Skyline Vet Pharma is developing products to address critical needs in the companion animal health industry as today’s pet owners expect veterinarians to provide pet health care nearly on par with human health care.
The company intends to bring several new products to the market over the next few years in three major therapeutic areas: pain/inflammation, cardiovascular disease and antimicrobials, areas that represent more than 60 percent of the prescriptions written by veterinarians.
|Founder / CEO||Serge Martinod|